Opaleye Management Inc. Glaukos Corp Transaction History
Opaleye Management Inc.
- $390 Million
- Q2 2024
Shares
1 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$706 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$246 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$240 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$209 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.16B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...